GLP-1 cash prices after Dec 31, 2026: $199 ends

Prices checked October 17, 2026

The table uses only pages opened that day. NovoCare states a month for the Wegovy pen as one box of four pens and a month for the Wegovy pill as one bottle of 30 tablets. A month for the Ozempic pen is one pen. TrumpRx's Foundayo page lists a quantity of 30 tablets and does not use the word month. TrumpRx's Zepbound page lists a vial, quantity 1, and also does not use the word month. Those TrumpRx figures are not relabeled as monthly prices here.

Lilly's full terms pages for Zepbound and Foundayo returned a security check and did not load, so no separate LillyDirect dollar amount was added. The Wegovy pill and the Ozempic tablet prices below are standard-offer prices. The savings-card pages do not put them in the limited-time section that ends December 31, 2026.

Wegovy: the $199 window, then $349 or $399

NovoCare's Wegovy pharmacy page says patients new to the Wegovy Savings Offer or NovoCare Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. The offer is for two monthly fills through December 31, 2026, then $349 a month for 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, or 2.4 mg, and $399 a month for Wegovy HD 7.2 mg. One month is one box of four pens. The pill is $149 for each month of 1.5 mg, $199 for 4 mg, and $299 for 9 mg and 25 mg. One month of the pill is one bottle of 30 tablets.

The savings-card page separates a limited-time offer from the standard offer. The limited-time price is $199 for the 0.25 mg and 0.5 mg pens. Eligible patients can use it if the offer is redeemed and the prescription is filled by December 31, 2026. It covers the first two 28-day fills, and the third fill reverts to the standard offer. A new patient, on that page, has not redeemed a savings offer for Wegovy injection in the past 365 days. The standard offer is $349 for one month at 0.25 mg, 0.5 mg, 1 mg, 1.7 mg, and 2.4 mg, and $399 for Wegovy HD 7.2 mg. The same page prices the tablets as a standard offer: $149, $199, $299, and $299 for 1.5 mg, 4 mg, 9 mg, and 25 mg.

TrumpRx uses the same pen dollars and adds a start date. It says new patients pay $199 for the first two monthly fills of 0.25 mg and 0.5 mg, only available for two monthly fills between November 17, 2025 and December 31, 2026, then $349 or $399 as above. It labels the original price, $1,349.02, as the wholesale acquisition cost. The pharmacy page also says a commercially insured patient may pay as little as $25, subject to a maximum savings of $100 a month, with government beneficiaries excluded. That sentence does not carry the December 31, 2026 end date written for the $199 pen offer. Novo Nordisk says it can modify or cancel the program at any time. The pages do not publish a different cash price dated January 1, 2027.

Ozempic: the same $199 window, then $349 or $499

NovoCare's Ozempic pharmacy page says patients new to the Ozempic Savings Offer or NovoCare Pharmacy pay $199 for each month of 0.25 mg and 0.5 mg. The offer is for two monthly fills through December 31, 2026, then $349 a month for 0.25 mg, 0.5 mg, or 1 mg, and $499 a month for 2 mg. One month is one box of one pen.

The savings-card page says eligible patients can use the limited-time injection offer if it is redeemed and the prescription is filled by December 31, 2026. It is for the first two monthly fills, and the third fill reverts to the standard offer. A new patient there is new to the Ozempic Savings Offer and has not participated in any other prior Ozempic savings offer in the past 365 days. The standard offer lists $349 for the 0.25 mg or 0.5 mg pen and for the 1 mg pen, and $499 for the 2 mg pen. The tablet section is a standard offer, not the limited-time section: $149 for 1.5 mg, $199 for 4 mg, and $299 for 9 mg, each for a 30-tablet bottle.

TrumpRx says new self-pay patients pay $199 for the first two monthly fills of 0.25 mg or 0.5 mg, only available for two monthly fills between November 17, 2025 and December 31, 2026, then $349 for 0.25 mg, 0.5 mg, or 1 mg, and $499 for 2 mg. It labels the original price, $1,027.51, as the wholesale acquisition cost. The commercial as-little-as-$25 line on the pharmacy page, capped at $100 a month with government beneficiaries excluded, is not given that December 31, 2026 end date.

Foundayo: two doses name a December 31 regular price

TrumpRx's Foundayo page says the price for the 2.5 mg dose is temporarily reduced through December 31, 2026, and that the regular price is $199. It says the 5.5 mg dose is temporarily reduced through the same date, and that the regular price is $299. The prices on the page, each for a quantity of 30 tablets, are $149 at 0.8 mg, $149 at 2.5 mg, $199 at 5.5 mg, and $299 at 9 mg, 14.5 mg, and 17.2 mg. The original price, $649, is labeled as the wholesale acquisition cost.

The December 31 sentence is written for 2.5 mg and 5.5 mg. The page does not write it for 0.8 mg or 9 mg. At 14.5 mg and 17.2 mg the page adds a different condition: $349 if a refill is more than 45 days from the last delivery or receipt, and the $299 figure for a first fill at that dosage or a refill within 45 days. That 45-day line is not a December 31, 2026 end date. The catalog has no commission-earning Foundayo medication price, so this article does not add a telehealth Foundayo dollar. The dose-by-dose walkthrough already published is the Foundayo cost note.

Zepbound: $449 is a 45-day refill price

TrumpRx's Zepbound vial page does not contain the words December 31 or temporarily. The vial prices, quantity 1, are $299 at 2.5 mg, $399 at 5 mg, and $449 at 7.5 mg, 10 mg, 12.5 mg, and 15 mg. At 7.5 mg the other price is $499 when a refill is more than 45 days from the last delivery or receipt. At 10 mg, 12.5 mg, and 15 mg that other price is $699. The page's tooltip for the primary price is a first fill at that dosage or a refill within 45 days of the prior delivery or receipt. The original price, $1,087, is labeled as the wholesale acquisition cost.

Nothing on that page says the $449 price expires on December 31, 2026, or that January 1, 2027 replaces it with $499 or $699. The higher figures are the miss-a-fill prices. Lilly's full Zepbound terms page did not load on October 17, 2026, so this article does not add a LillyDirect sentence beyond what TrumpRx itself publishes.

Catalog telehealth prices beside those offers

The program pages opened October 17, 2026 read the same commission-earning catalog the rankings use. A continuing price is the calendar-month price after any introductory fill. It is not a prepaid effective rate.

Wegovy injection, rechecked 19 October 2026: four providers publish a calendar-month continuing price, from $349 to $1,695, median $1,522. Sesame Care is $349 a month after two months at $199, plus $99 a month for care, and the catalog condition says that $199 offer ends December 31, 2026. The page dates that row to October 2, 2026. RxSpan MD lists $1,349. Eden Health and GobyMeds list $1,695. Sprout Health's homepage does not publish a Wegovy price. The $1,188 on that page is the compounded semaglutide 12-month upfront total. DudeMeds' old $1,500 shop figure is not ranked. GobyMeds was checked October 17, 2026. RxSpan MD and Eden Health were checked September 14, 2026.

Ozempic injection, rechecked 18 October 2026: three continuing prices, from $1,299 to $1,399, median $1,299. Gala Health and RxSpan MD are $1,299. Eden Health is $1,399. DudeMeds' old $1,500 shop figure is not ranked. The remaining rows were checked September 14, 2026.

Zepbound, rechecked 19 October 2026: four continuing prices, from $299 to $1,399, median $1,234. Sesame Care's comparison figure is the 2.5 mg price of $299, plus $99 care. The same catalog condition lists $398 at 5 mg, $499 at 7.5 mg, and $698 at 10 mg, 12.5 mg, and 15 mg, checked October 2, 2026. Those are Sesame's dose prices, not the TrumpRx vial ladder. RxSpan MD lists $1,069, checked 19 October 2026. Eden Health and GobyMeds list $1,399. Sprout Health's homepage does not publish a Zepbound price. The $1,788 on that page is the compounded tirzepatide 12-month upfront total. DudeMeds' old $1,350 shop figure is not ranked. GobyMeds was checked October 17, 2026.

Compounded semaglutide and compounded tirzepatide are different products. FDA's telehealth page says not to describe a compounded drug as a generic version of an FDA-approved drug or as the same as an approved drug, and not to claim FDA approval. Rechecked 19 October 2026, compounded semaglutide continuing prices run from $99 to $299, median $165, across 13 providers. PlexusDx month-to-month is $149. Eden's compounded price is not ranked. Compounded tirzepatide continuing prices run from $149 to $399, median $314, across 12 providers. PlexusDx month-to-month is $189, and CoreAge Rx's $129 is $1,548 paid for 12 months. Neither range is a Wegovy, Ozempic, or Zepbound price after January 1.

A compounded drug is not FDA-approved and is not the same as Wegovy, Ozempic, Zepbound, or Foundayo. The catalog rows are published offers, not a finding that a compounded product matches an approved drug.